Molecular formula: C47H58N12O6

Molar Mass: 887.0

Sequence: His-D-2-Methyl-Trp-Ala-Trp-D-Phe-Lys-NH2

Purity (HPLC): 98,6%

Specification: 5mg/vial

Hexarelin (Examorelin) is a high-efficiency synthetic and highly selective ghrelin receptor agonist (GHSR). It is a peptide by structure.

Hexarelin significantly and dose-dependently increases the level of the growth hormone (GH) in the blood plasma, slightly and dose-dependently stimulates the release of prolactin, adrenocorticotropic hormone (ACTH), and cortisol, and increases the level of insulin-like growth factor (IGF-1). After subcutaneous injection of Hexarelin, the concentration of the growth hormone increases within 25-35 minutes regardless of the time of day and the presence of somatostatin in the serum and then decreases to the initial level within several hours. Hexarelin releases more quantity of the growth hormone than the growth hormone-releasing hormone (GHRH) and has a synergistic effect on the release of the growth hormone (GH) in combination with GHRH (CJC-1295 without DAC; CJC-1295 with DAC). For medicinal purposes, Hexarelin is used to treat diseases caused by growth hormone deficiency.

It should be noted that with long-term use, a partial and reversible tolerance to the release of the growth hormone (GH) caused by the Hexarelin action is developed.

For research purposes only.